It Is Too Early to Consider Serum Bilirubin as a Definitive Novel Biomarker for Carotid Atherosclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

It Is Too Early to Consider Serum Bilirubin as a Definitive Novel Biomarker for Carotid Atherosclerosis

Published:2023-10-16 Issue: Volume: Page:
ISSN:0003-3197
Container-title:Angiology
language:en
Short-container-title:Angiology

Author:

Qin Lu¹²^ORCID,Wang Haoyuan³^ORCID,Zhou Wanru¹²⁴^ORCID,Wang Hebo¹²⁴^ORCID

Affiliation:

1. Department of Neurology, Hebei General Hospital Affiliated to Hebei Medical University, Shijiazhuang, China

2. Hebei Provincial Key Laboratory of Cerebral Networks and Cognitive Disorders, Shijiazhuang, China

3. Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

4. Department of Neurology, Hebei North University, Zhangjiakou, China

Funder

Natural Science Foundation of Hebei Province

Central Government Guides Local Funds for Science and Technology Development

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/00033197231208747

Reference5 articles.

1. Serum Bilirubin as a Novel Biomarker of Carotid Atherosclerosis

2. Longitudinal Associations Between Serum Bilirubin Level and Carotid Atherosclerosis Plaque in a Health Screening Population

3. Biomarkers of liver diseases

4. Combined effects of hypertension, hyperlipidemia, and diabetes mellitus on the presence and severity of carotid atherosclerosis in community-dwelling elders: A community-based study

5. Biomarker definitions and their applications

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP